PO-503 HDAC inhibitor resistance in colorectal cancer: RAS and AMP; MYC – the partners in crime

Autor: Ispasanie, S., Kistler, S., Heberle, A., Uhlitz, F., Kasack, K., Dittmar, G., Blüthgen, N., Thedieck, K., Campbell, S., Sers, C.
Zdroj: In ESMO Open 30 June-3 July 2018 3 Supplement 2:A218-A219
Databáze: ScienceDirect